Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

12th World AIDS Conference

counsellors * CSF 43

-Keyword

Abstract--

Keyword

Abstract--

ges/dilemmas faced by in HIV/AIDS/Problems/challe
I load, and CD4+ T-cell count /The role of HIV-1 phenotype in viral
al AIDS after CD4+ cell falls below 200//zl/Predictive value
Viral load and CD4-cell under a triple-therapy with nelfinavir
/Changes in CD4+ cell and the risk of opportunistic infectio
DS diagnosis by a CD4 of <200 cells/pL/AIDS diagnosis by
nfection and CD4+ cell in peripheral blood/HPV DNA in cer
Viral load and CD4 cell in injecting drug users (IDUs) newly i
on drug users/CD4 cell and viral load in HTLV-II and HIV copatients with <50 CD4 /Impact of indinavir with zidovudine
roportional to CD4 cell and plasma HIV RNA copy number/
als with stable CD4 cell above 200/gL/Withdrawal of primar
y on viral load and CD4 in HIV infected children <36 months
epression and CD4 cell as predictors of quality of life in HIVc neuropathy and CD4 /Sexual dysfunction in patients with
patients with CD4 cells below 50 treated with combined anti
S)/HIV RNA, CD4+ cell, and immune activation markers pre
Significance of CD4 cell and HIV viral load on CMV retinitis tr
t questioning versus pill as an assessment of compliance/V
Plasma viral load, CD4 and p24 antigenemia in HIV-infecte
of the total lymphocyte to accurately predict the CD4+ T-cel
nts with >400 CD4 cell /Longitudinal study of CD8 T cell acti
and CD4+ lymphocyte as a response to treatment changes
viral load (VL) and CD4 /Changing highly active antiretrovira
ucosal lesions, CD4, viral load and other covariates in wo
according to initial CD4 /Virological response to protease in
al load and CD4 T cells /Quadritherapy including RTV/SQV
een viral load and CD4 in patients with and without treatme

60227
12126
12133
12256
12331
13214
13293
191*/13302
13326
14339
21165
22179
22364
24223
32125
32149
506*/32167
32243
32373
42180
42187
42190
43473
60178
60299
60812
60966
60991

+;, Tuberculin+ Adults ( CPCRA004 /ACTG177/CDC/PAHO)/A ran 447*/22126
omen in 1996-1997 ( CPCRA 038)/Body composition in HIV-inf 32169
ical research on AIDS ( ) in 1996-1997/Body cell mass (B 42333
CD4 < 200 cells/mm3: 038/Protein intake is associated 42339
d HIV disease from the 039 trial/Serum carnitine levels in 60508
nomes in cell culture by CpG methylation/Inactivation and reactiva 11127
ymphocyte precursors ( CPLp )/Detection of memory T cells in HIV 216*/41103
tudy of sexual norms of crack-using women/Sharing men and HI 23418
V risk reduction among women/Motherhood as an o 43264
ntion for urban and rural crack users/HIV sexual risk reduction: An 14165

al staining, microscopic count
nostic value of CD4 cell count

V-2/CD4+ lymphocyte
roon/CD4+, CD8+ cell
ve subjects with CD4+
ral therapy lowers CD8
It population with CD4
tries/Total lymphocyte
sma viral load and CD4
tory cohort/Serial CD4
RT) on CD4 lymphocyte
s relation to CD4 T-cell
sma viral load and CD4
mple in the US/Culture
ies in plasma and CD4
ating naive CD8+ T cell
ents with CD4+ T cells
tients with low CD4 cell
ith CD4+T lymphocyte
I/CD4+ T lymphocytes
IV RNA levels and CD4
nd total lymphocyte cell
en helper T-lymphocyte
an HIV population/CD4
HIV+ adults with CD4+
V RNA levels and CD4
e of monitored CD4 cell
naive patients with CD4
CD8 lymphocyte subset
nfection in a discordent

ing methods in estimation of periphe 60416
s: The EuroSIDA study/Impact of an 12106
and HIV disease progression in su 12113,CD4/CD8 ratio and clinical feature 12138
>400 cells/p l and viral load >5000 286*/12204

toward the normal range/Early inte
150-350/mm3 and predominantly i
as an alternative to CD4 counts in r
before and after anti-tuberculosis t
following HIV seroconversion in a
in France/Impact of highly active a
and disease progression in a Danis
in surviving and non-surviving HIV-: Understanding the context of unpr
to human papillomavirus (HPV) pr
/Highly active antiretroviral therapy
from 200 to 500//l and plasma RN
/Antiretroviral combination therapy
and T cell function in long-term AID
of HIV infected women seeking an
when assessing all-cause mortalit
to opportunistic infections in PHIV/
obtained by zymmune and flow cyt
as a surrogate marker in Indian HI
200-499/mm3/Effects of aerobic a
in HIV positive subjects/The effect: Predictions of the AIDS epidemic i
of 20-300/mm3/A randomized stu
at different ages among HIV-1 peri
couple: A study conducted in Littoral, Cam

12215
12241
12426
13271
13316
13318
13327
13329
14223
22317
22345
22383
22408
31109
33275
42159
42189
42193
42194
42328
60159
60237
60397
60790
22200

ommercial sex among smokers in a sample of injecting dru
on condom use/Use of cocaine after HIV diagnosis and imp
ment African-American abusers/HIV risk and alcohol use in
haviors associated with cocaine use: Implications for risk red
nce in male and female users attending a residential drug-fr
reduction programs for users/Using perceived status and p
V risk reduction among users/Behavioral beliefs and situati
f injection drug use and smoking for HIV seroprevalence/Re
f HIV transmission/The crime of HIV transmission/The
ures in South America/ Criminal laws and their impact on the esta
smission in the UK/The criminalization of HIV transmission in the
ted patients/Indinavir ( Crixivan ~) in combination with two nucleo
are for migrant labors cross-border neighbouring countries Thai
w of Chinese-Myanmar drug demand reduction and
HIV-1 clade-B infection/ Cross-clade envelope gp160, gag p55 an
h Americans and Thais/ cytotoxic T cell response to H
fected Ugandan adults/ HIV-1 specific cytotoxic T lym
nant gp120 SF2/HIV-1 cross-clade lymphoproliferative response
city and sexual health: Cross-cultural experiences in learning ab
esistance: A model for cross-cultural treatment education to ena
uritius and Sri Lanka/A cross-national analysis of female adolesc
tive patients frequently cross-react with different HIV-1 gag subty
kocytoclastic vasculitis; cross-reactivity with ritonavir/Indinavir-in
enotypic and genotypic cross-resistance among protease inhibito
al sequence variability: Cross-sectional study representing all sta
en with HIV infection/A cross-sectional descriptive survey of fact
ention and behavior: A and prospective design c
ical manifestations - A study in a cohort of HIV-in
rapine: A retrospective, cross-study analysis/Once-daily dosing o
on of HIV/The Thai Red Cross donation campaign to prevent moth
tance drivers (LDD) in River State, Nigeria/The impact of a
nd confers little NRTI cross resistance/3TC resistance is associ
Curbing the menace of border prostitution in the spread of H
est Bengal/Developing sectoral networks in India: A case st
ntiretroviral therapy/A sectional evaluation of participants e
est London/"Who's cruising who?" A study of the socio-sexual
ho have sex with men in areas in downtown Guatemala Ci
ront line pioneer ASO's crusade despite resource crunch/Front lin
obulin formation/Mixed cryoglobulin emia in HIV-1 infected patien
HIV positive patient with cryoglobulinemia /Successful antiretrovir
obulin formation/Mixed in HIV-1 infected patien
al technique utility in the cryptoccocosis diagnosis in Cuban VIH/
in Africa/The impact of cryptococcal disease and therapy implica
o amphotericin alone in meningitis/Amphotericin co
dult AIDS patients with meningitis/A pilot study of t
V positive patients with infections at Mpilo Central H
patients/Asymptomatic meningitis in 2 HIV+ patient
-based surveillance for cryptococcosis in the US: 1993-94 vs. 19
factors of mortality from /Conditioning factors of m
ects of lanoconazole on Cryptococcus neoformans infection in M
eptibility of 23 strains of neoformans isolated from
rculosis/Regulation of neoformans infection in M
e 2 T cell responses on neoformans infection in M
isk of presentation with cryptosporidiosis as an AIDS-defining co
ness and importance of cryptosporidium - A 7-year study in Calc
e and consequences of oocysts in drinking wate
/Waterborne diseases, and water quality laws/
ed patients/Infusion of cryropreserved autologous lymphocytes
bacavir (ABC) reduces CSF viral load in HIV-infected children (CN

23212
23364
23421
23425
23560
43241
60741
60850
44113
33397
44117
12350
42427
43194
601 */31122
602*/31128
31139
497*/21201
14224
32363
14124
31149
60274
230*/42195
11158
14187
24171
61004
12360
23278
33373
32299
33355
34374
60465
13424
33365
44256
60655
22330
60655
60066
22223
22226
60231
60282
60452
13240
22225
11235
31213
60313
60314
13242
31222
31226
43559
60771
12252

dy/Confidentiality and HIV counselling encourage client d 593*/24323
tuation/The efforts of a living with AIDS: An useful instrum 34302
mong male homosexual couples: Methodological issues/Level of a 14105
ng serodiscordant male /HAART, attitudes, and risk beha 643*/14136
sexual HIV-discordant /Awareness of PEP and viral supp 14146
mong HIV discordant in northern Thailand/Factors influ 14169
ussion among married and its implications in STD/HIV/AI 205*/14213
Switzerland, 1997/Gay and protection against HIV/AIDS, 23128
cordance rates among requesting HIV counselling and te 23149
of Uganda/Discordant! A silent high risk group in HIV tra 23165
igh risk HIV negative: Preliminary results from a study a 23166
scordant heterosexual /Methodologic issues in outcome 258*/24169
ntercourses among the of HIV infected partners/Awarene 24344
scordant heterosexual (female infected with HIV): Issues 32425
/A prospective study of who use the female condom: Exp 33132
erodiscordant married undergoing couples counselling a 33268
and testing on married in three developing countries: Re 33288
ng and testing to young in rural regions of western Kenya/ 43114
sexual HIV-discordant in northern California is influence 43428
Profile of heterosexual with HIV infection attending in a re 60707
hlamydia trachomatis in Coventry, UK 1992-1996/Socio-demogra 23373
oms and complacency/ Cowboys, condoms and complacency/ 43563

pine (NVP) can reduce
the cerebrospinal fluid (
antitation of JC virus in
A in cerebrospinal fluid (
n cerebrospinal fluid (
ve disorder/Change in
d in cerebrospinal fluid (
s in cerebrospinal fluid (
and cerebrospinal fluid (
es/Cerebrospinal fluid (
od-cerebrospinal fluid (

HIV-1 viral load in pediatric patients wi 12253
) of AIDS patients without CMV diseas 22262
AND urine prognostic value of CSF JC 22266
) as predictive value of primary cerebr 22324
) HIV-RNA levels: Preliminary results/ 32197
RNA level correlates with the effects o 32198
), plasma and CNS involvement in HIV 32201
) compartment/Evidence for independ 563*/32284
) polymerase chain reaction (PCR)/N 41156
) versus plasma HIV RNA levels in pati 42170
) barrier/Brain delivery of anti-HIV dru 42270